Perrigo Company plc (PRGO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePRGO / S&P -0.74% / 15.20% |
LosePRGO / S&P -4.19% / 15.00% |
WinPRGO / S&P 2060.34% / 50.40% |
| 2026-Q11/3 |
LosePRGO / S&P -21.11% / -4.33% |
LosePRGO / S&P -3.62% / 11.30% |
WinPRGO / S&P 901.53% / 27.70% |
| 2025-Q41/3 |
LosePRGO / S&P -37.49% / 2.65% |
LosePRGO / S&P -2.75% / 9.00% |
WinPRGO / S&P 724.00% / 13.40% |
| 2025-Q30/3 |
LosePRGO / S&P -15.62% / 8.12% |
LosePRGO / S&P -2.51% / 4.61% |
LosePRGO / S&P -67.24% / 13.45% |
| 2025-Q20/3 |
LosePRGO / S&P -3.68% / 10.94% |
LosePRGO / S&P -2.31% / 4.83% |
LosePRGO / S&P -36.26% / 10.63% |
| 2025-Q12/3 |
WinPRGO / S&P 10.18% / -4.27% |
LosePRGO / S&P -4.84% / 4.98% |
WinPRGO / S&P 2083.33% / 10.57% |
| 2024-Q41/3 |
LosePRGO / S&P -1.04% / 2.41% |
LosePRGO / S&P -6.06% / 5.25% |
WinPRGO / S&P 1288.89% / 6.15% |
| 2024-Q31/3 |
LosePRGO / S&P 3.12% / 5.89% |
LosePRGO / S&P -5.63% / 5.89% |
WinPRGO / S&P 3766.67% / 6.11% |
| 2024-Q21/3 |
LosePRGO / S&P -19.42% / 4.28% |
LosePRGO / S&P -4.36% / 5.38% |
WinPRGO / S&P 82.00% / 5.12% |
| 2024-Q10/3 |
LosePRGO / S&P 1.02% / 10.56% |
LosePRGO / S&P -0.07% / 5.71% |
LosePRGO / S&P -94.23% / 5.59% |
| 2023-Q40/3 |
LosePRGO / S&P 1.63% / 11.69% |
LosePRGO / S&P 4.58% / 6.81% |
LosePRGO / S&P -91.35% / 7.78% |
| 2023-Q30/3 |
LosePRGO / S&P -5.17% / -3.27% |
LosePRGO / S&P 5.74% / 7.52% |
LosePRGO / S&P -96.25% / -5.03% |
| 2023-Q20/3 |
LosePRGO / S&P -4.54% / 8.74% |
LosePRGO / S&P 6.60% / 9.50% |
LosePRGO / S&P -42.53% / -8.57% |
| 2023-Q11/3 |
LosePRGO / S&P 6.00% / 7.50% |
LosePRGO / S&P 8.46% / 10.77% |
WinPRGO / S&P 26.83% / -15.69% |
| 2022-Q41/3 |
LosePRGO / S&P -3.63% / 7.56% |
LosePRGO / S&P 7.56% / 11.88% |
WinPRGO / S&P 100.00% / -17.99% |
| 2022-Q30/3 |
LosePRGO / S&P -11.49% / -4.88% |
LosePRGO / S&P 7.69% / 13.47% |
LosePRGO / S&P -57.22% / -1.41% |
| 2022-Q21/3 |
WinPRGO / S&P 6.26% / -16.10% |
LosePRGO / S&P 7.33% / 13.71% |
LosePRGO / S&P -65.88% / 11.04% |
| 2022-Q11/3 |
WinPRGO / S&P -0.47% / -4.60% |
LosePRGO / S&P 4.69% / 15.97% |
LosePRGO / S&P -51.19% / 42.23% |
| 2021-Q40/3 |
LosePRGO / S&P -17.26% / 11.03% |
LosePRGO / S&P 1.23% / 15.00% |
LosePRGO / S&P -56.30% / 96.40% |
| 2021-Q33/3 |
WinPRGO / S&P 3.84% / 0.58% |
WinPRGO / S&P 20.55% / 10.77% |
WinPRGO / S&P 3640.00% / 69.42% |
| 2021-Q22/3 |
WinPRGO / S&P 13.87% / 8.55% |
WinPRGO / S&P 13.10% / 6.58% |
LosePRGO / S&P -246.55% / 51.81% |
| 2021-Q11/3 |
LosePRGO / S&P -8.98% / 6.17% |
WinPRGO / S&P 6.25% / -1.06% |
LosePRGO / S&P -222.63% / 7.39% |
| 2020-Q41/3 |
LosePRGO / S&P -2.14% / 12.15% |
WinPRGO / S&P 5.64% / -3.72% |
LosePRGO / S&P -211.21% / -33.42% |
| 2020-Q30/3 |
LosePRGO / S&P -16.58% / 8.93% |
LosePRGO / S&P -28.01% / -2.04% |
LosePRGO / S&P -102.78% / -27.10% |
| 2020-Q21/3 |
LosePRGO / S&P 15.40% / 20.54% |
LosePRGO / S&P -23.07% / -0.46% |
WinPRGO / S&P 171.88% / -27.11% |
| 2020-Q12/3 |
WinPRGO / S&P -6.56% / -19.60% |
LosePRGO / S&P -19.42% / 3.47% |
WinPRGO / S&P 65.06% / -14.75% |
| 2019-Q41/3 |
LosePRGO / S&P -7.18% / 9.07% |
LosePRGO / S&P -18.21% / 5.36% |
WinPRGO / S&P 15.05% / 2.99% |
| 2019-Q32/3 |
WinPRGO / S&P 17.90% / 1.70% |
LosePRGO / S&P -2.28% / 5.02% |
WinPRGO / S&P 109.30% / 0.21% |
| 2019-Q20/3 |
LosePRGO / S&P -0.66% / 4.30% |
LosePRGO / S&P -5.41% / 6.64% |
LosePRGO / S&P -61.45% / 8.65% |
| 2019-Q11/3 |
WinPRGO / S&P 24.79% / 13.65% |
LosePRGO / S&P -5.64% / 8.12% |
LosePRGO / S&P -8.79% / 14.29% |
| 2018-Q40/3 |
LosePRGO / S&P -45.10% / -13.52% |
LosePRGO / S&P -4.34% / 9.05% |
LosePRGO / S&P 10.71% / 18.23% |
| 2018-Q30/3 |
LosePRGO / S&P -2.65% / 7.71% |
LosePRGO / S&P -3.50% / 10.21% |
LosePRGO / S&P -109.39% / 19.06% |
| 2018-Q20/3 |
LosePRGO / S&P -12.30% / 3.43% |
LosePRGO / S&P -2.13% / 9.03% |
LosePRGO / S&P -108.07% / 14.46% |
| 2018-Q10/3 |
LosePRGO / S&P -4.16% / -0.76% |
LosePRGO / S&P -3.08% / 7.68% |
LosePRGO / S&P -103.82% / 12.46% |
| 2017-Q40/3 |
LosePRGO / S&P 3.15% / 6.64% |
LosePRGO / S&P -6.33% / 7.03% |
LosePRGO / S&P -103.00% / 13.82% |
| 2017-Q31/3 |
WinPRGO / S&P 12.32% / 4.48% |
LosePRGO / S&P PRGO unavailable / 5.68% |
LosePRGO / S&P PRGO unavailable / 17.57% |
| 2017-Q21/3 |
WinPRGO / S&P 14.00% / 3.09% |
LosePRGO / S&P PRGO unavailable / 4.83% |
LosePRGO / S&P PRGO unavailable / 17.74% |
| 2017-Q10/3 |
LosePRGO / S&P -20.06% / 6.07% |
LosePRGO / S&P PRGO unavailable / 3.67% |
LosePRGO / S&P PRGO unavailable / 13.32% |
| 2016-Q40/3 |
LosePRGO / S&P -9.71% / 3.82% |
LosePRGO / S&P PRGO unavailable / 2.09% |
LosePRGO / S&P PRGO unavailable / 7.05% |
| 2016-Q30/3 |
LosePRGO / S&P 1.99% / 3.85% |
LosePRGO / S&P PRGO unavailable / 0.20% |
LosePRGO / S&P PRGO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PRGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -36.50% | 20.78% |
| Annualized return | -36.50% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PRGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -57.20% | 83.14% |
| Annualized return | -15.61% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PRGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -79.58% | 319.30% |
| Annualized return | -14.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |